Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today ...

A new real-time monitoring system captures minute-by-minute changes in toxic metals resulting from traffic pollution.

Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today ...

A delay, as opposed to a firm stagnation, then, but one unfolding over several years. This applies not only to SMEs, but to ...

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the appointment of Babar Ghias as chief financial officer (CFO) and head of corporate development.

Hair transplant is probably the most life changing breakthrough until humanity discovers the cure for cancer.It's almost funny that for thousands ...

Tired of electric vehicle fantasies that never leave the drawing board? Meet the VoltAero Cassio 330. It’s an electric-hybrid ...

National Footprint of NEXICART-2 Trial Sites Expanded - - On track for first Biologics License Application (BLA) approved cell therapy in unaddressed orphan indication - - NEXICART-2 interim results ...

The Australian sharemarket shed its early morning gains rising above 8600 points in the opening minutes of trading on Friday ...

Companies across Europe are developing the next generation of sensors for medical applications, from Covid-19 testing to ...

Regenerative medicine is gaining serious momentum in 2025 as scientific advances, regulatory progress, and payer acceptance converge to push the sect ...

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the appointment of Babar Ghias as chief financial officer (CFO) and head ...